1st Circ. Won't Revive Spinal Therapy Co. Investor Suit
By Melissa Daniels ( January 9, 2017, 10:38 PM EST) -- A spinal cord therapy company once again dodged a putative class action by investors alleging it lied in public statements about drug trial opportunities when the First Circuit on Monday said a lower court had rightfully tossed their arguments that the company hid information about U.S. Food and Drug Administration communications. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.